NuPathe: FDA wants more data on migraine patch
Marketwatch
[video] The Next Big Thing in Biotech: Nupathe
TheStreet.com
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
- Adcetris
- Affymax
- Alexion
- Alexza
- Alimera
- Alkermes
- Amlyin
- Antares
- Anturol
- AstraZeneca
- AZ-004
- Bio-T-Gel
- BioSante
- biotech
- Bristol-Myers Squibb
- Bydureon
- Corcept Therapeutics
- Corlux
- crizotinib
- Dapagliflozin
- Dendreon
- drug approvals
- Eli Lilly
- EXPAREL
- Eyelea
- FDA
- Iluvien
- Incyte
- Levadex
- MAP Pharmaceuticals
- Novartis
- NuPathe
- Pacira
- peginesatide
- Pfizer
- Provenge
- Regeneron
- Roche
- ruxolitinib
- Seattle Genetics
- Soliris
- Spectrum
- Takeda
- Teva Pharmaceuticals
- Zelboraf
- Zelrix
- Zevalin
Biotech Calendar: Key Dates for August
TheStreet.com